Latest Capital Structure News

Magellan Financial Group has applied for quotation of over 15 million new shares following a recent transaction, alongside announcing a $20 million Share Purchase Plan targeting further capital raising.

Pioneer Credit has raised its FY26 net profit after tax guidance to at least $23 million, driven by significant interest savings from repricing its debt facilities. This marks a notable upgrade reflecting stronger earnings and a healthier capital structure.

Kingfisher Mining and Broken Hill Mines have inked a decade-long agreement to leverage existing processing infrastructure, accelerating Kingfisher’s pathway to production in the Broken Hill region.

Carnaby Resources has reported a standout drill result of 18 metres at 5.0% copper equivalent at its Trek 2 prospect, signalling significant growth potential beyond current resource estimates at the Greater Duchess Copper Gold Project.

Manuka Resources has locked in a US$30 million senior secured loan facility with Nebari to refinance debt and fund production at its Wonawinta and Canbelego mines, positioning itself to capitalise on the current precious metals cycle.

Oldfields Holdings Limited remains suspended from ASX trading following its failure to lodge critical half-year financial reports after announcing a capital raising.

Cosmos Exploration Limited has voluntarily suspended its shares from ASX trading as it prepares to announce significant developments involving an Option Agreement and a capital Placement.

MCS Services Limited has reported a significantly reduced half-year loss and announced plans to sell its Highways Traffic subsidiary, aiming to strengthen its financial position amid ongoing challenges.

Nexion Group Ltd reports a striking turnaround to a $6.3 million net profit in H1 2026, driven by gains from subsidiary sales, while continuing operations still face losses amid efforts to regain ASX trading status.

FBR Limited reports a significant reduction in half-year losses alongside new robotic product launches, yet cash flow challenges raise questions about its financial sustainability.

Osteopore Limited reported an 11% increase in revenue to $3.06 million for 2025, alongside a wider net loss of $3.72 million as it invests heavily in product development and regulatory compliance. The company also expanded its footprint with a new Singapore subsidiary.

Nexalis Therapeutics reported a widening loss of $1.83 million for 2025, reflecting increased investment in product development and marketing. Despite the loss, the company boosted its cash reserves through equity raises and borrowings.